Study Supports Expanding Pediatric Cochlear Implant Candidacy to Younger Ages and Residual Hearing

A multicenter study published in The Laryngoscope finds strong efficacy outcomes for cochlear implantation in children as young as 7 months and in those with residual hearing, lending clinical weight to calls for updated FDA candidacy criteria....

Continue reading at Hearing Review →

This multicenter evidence supports advocating for earlier cochlear implant referral in infants under 12 months and in children with residual hearing; audiologists should document candidacy discussions in light of evolving evidence, but FDA criteria remain unchanged until formally revised.

Expanding pediatric cochlear implant candidacy to younger infants and those with residual hearing could significantly improve long-term language outcomes by capitalizing on critical windows of auditory brain development.

1. 01Multicenter study published in The Laryngoscope supports CI efficacy in children as young as 7 months.
2. 02Children with residual (some remaining) hearing also showed strong outcomes post-implantation.
3. 03Current FDA minimum age threshold of 12 months is challenged by these findings.
4. 04Authors call for formal revision of pediatric cochlear implant candidacy criteria.
5. 05Earlier implantation aligns with evidence on critical periods for auditory brain development.

Journal

The Laryngoscope

Publication type

research_article

Evidence level

2b

Population

Pediatric patients as young as 7 months, including those with residual hearing, assessed for cochlear implant candidacy and outcomes across multiple centers

Intervention

Cochlear implantation in young infants and children with residual hearing